Suppr超能文献

头孢西丁诱导免疫性溶血性贫血严重病例。

A severe case of cefoxitin-induced immune hemolytic anemia.

机构信息

Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.

出版信息

Acta Haematol. 2010;124(4):197-9. doi: 10.1159/000320169. Epub 2010 Nov 2.

Abstract

Drug-induced immune hemolytic anemia is a rare but underdiagnosed and potentially fatal condition. We report a case of severe hemolytic anemia induced by cefoxitin in a 45-year-old woman admitted with menometrorrhagia. Hemoglobin levels reached a nadir of 4.7 g/dl approximately 72 h after cefoxitin initiation, and hemolysis resolved when cefoxitin was discontinued and prednisone 1 mg/kg was initiated. A transfusion reaction workup revealed no abnormalities. Direct antiglobulin testing was weakly positive with anti-C3. The patient's plasma and RBC eluate reacted with cefoxitin-treated RBCs but not with untreated RBCs in the presence or absence of cefoxitin.

摘要

药物诱导的免疫性溶血性贫血是一种罕见但诊断不足且可能致命的疾病。我们报告了一例 45 岁女性因头孢西丁引起的严重溶血性贫血病例,该患者因月经过多入院。在开始使用头孢西丁约 72 小时后,血红蛋白水平降至最低点 4.7 g/dl,当停止使用头孢西丁并开始使用 1 mg/kg 的泼尼松龙后,溶血得到缓解。输血反应检查无异常。直接抗球蛋白试验呈弱阳性,与抗 C3 反应。在存在或不存在头孢西丁的情况下,患者的血浆和 RBC 洗脱液与头孢西丁处理的 RBC 反应,但与未处理的 RBC 不反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验